FibroBiologics(FBLG) - 2024 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | (Mark One) | | | --- | --- | | ☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) | | | OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the fiscal year ended December 31, 2024. | | | or | | ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) | | | OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the transition period from [—Date—] to [—Date—] | | | Commission File Number: 001-41934 | FibroBiologics, Inc. (Exact name of reg ...